Meeting
2024 ASCO Gastrointestinal Cancers Symposium
The impact of Wnt pathway alterations including RNF43, GNAS, CTNNB1, and APC on prognosis and potential therapeutic vulnerability in pancreatic adenocarcinoma (PDAC).
Authors
Naoko Takebe
Elkridge, MD
Naoko Takebe , Edik Matthew Blais , Jasmine Huynh , Dzung Thach , Patricia Miren de Arbeloa , Lynn McCormick Matrisian , Emanuel Petricoin III, Michael J. Pishvaian , Vincent Chung , Patrick M Boland , Rona Yaeger , Raymond Couric Wadlow , Andrew Eugene Hendifar , Avinoam Nevler , Timothy Lewis Cannon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 698)
DOI
10.1200/JCO.2024.42.3_suppl.698
Abstract #
698
Poster Bd #
N7
Abstract Disclosures
Similar Posters
First Author: Shafia Rahman
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association between TP53 gain of function and loss of function mutational subgroups and survival in pancreatic adenocarcinoma.
First Author: Nitzan Zohar
Poster
2022 ASCO Annual Meeting
Mutational landscape of pancreatic adenocarcinoma identified by prospective clinical sequencing in a nationwide cancer network.
First Author: Katherine E Poruk
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk